Factor X - Bio Products Laboratory

Drug Profile

Factor X - Bio Products Laboratory

Alternative Names: Coagadex

Latest Information Update: 14 Jul 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bio Products Laboratory
  • Class Antihaemorrhagics; Blood coagulation factors; Coagulants
  • Mechanism of Action Blood coagulation factor replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Factor X deficiency
  • New Molecular Entity No

Highest Development Phases

  • Marketed Factor X deficiency

Most Recent Events

  • 13 Jul 2017 Adverse events and efficacy data from a phase III trial in Factor X deficiency released by Bio Products Laboratory
  • 01 Oct 2016 Bio Products Laboratory completes a phase-III clinical trial in Factor X deficiency (Prevention, In children, In infants, In neonates) in United Kingdom (IV) (NCT01721681)
  • 06 Jun 2016 Launched for Factor X deficiency in United Kingdom (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top